Abstract
Evaluation of the immunogenicity of embryonic stem cell derived differentiated cells is important for their potential application in cell replacement therapies and transplantations. Low immunogenicity or even an immune privileged status would enable their general use in allogeneic settings and therefore supply an unrestricted source. Based on conflicting data in terms of immunogenicity published for mouse and human ES-derived cells, the rat model was used to complement the knowledge in this specific area by a set of in vitro test systems using endothelial ES cell derivatives.
This chapter describes the strategies and methods used to analyze immunogenicity of rat ES cell derived endothelial cells (RESC) in comparison to adult mature rat endothelial cells (EC). In a first characterization step, the endothelial nature of rat ES cell derived endothelial cells was proved by labelling with von Willebrand factor (vWF) as well as testing tube formation capacity on an extracellular matrix. The RESC can be characterized by their constitutive or cytokine-induced expression level of the Major Histocompatibility Complex (MHC) antigens class I and class II by Fluorescence Activated Cell Sorter (FACS) technology. Moreover, regulation of transcription factors involved in the IFNγ signaling pathway could be evaluated by detecting either the phosphorylation status by specific intracellular antibody staining followed by flow cytometric measurement or by analyzing the mRNA expression level by quantitative RT-PCR. By stimulating the RESC with IFNγ and coculturing with Carboxy-fluorescein diacetate succinimidyl ester (CFDA-SE)-labelled CD4+ rat T cells, the ability of RESC to induce proliferation was analyzed by FACS technology. Allo-reactive cytotoxic T cells were generated in a mixed lymphocyte culture (MLC) with lymph node cells from two MHC-disparate rat strains and used to determine the susceptibility of RESC to lytic processes. Therefore, RESC were labelled with calcein and the release of this fluorochrome after coculture was measured. To analyze the response to humoral attacks, RESC were incubated with allo-antibody containing sera and rabbit complement and then cell damage was assessed by 7-actinomycin D (7-AAD) incorporation into the DNA using FACS analysis.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Li L, Baroja ML, Majumdar A, Chadwick K, Rouleau A, Gallacher L, Ferber I, Lebkowski J, Martin T, Madrenas J, Bhatia M (2004) Human embryonic stem cells possess immune-privileged properties. Stem Cells 22:448–456
Bonde S, Zavazava N (2006) Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients. Stem Cells 24:2192–2201
Kofidis T, deBruin JL, Tanaka M, Zwierzchoniewska M, Weissman I, Fedoseyeva E, Haverich A, Robbins RC (2005) They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte-based host immune response. Eur J Cardiothorac Surg 28:461–466
Swijnenburg RJ, Tanaka M, Vogel H, Baker J, Kofidis T, Gunawan F, Lebl DR, Caffarelli AD, de Bruin JL, Fedoseyeva EV, Robbins RC (2005) Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium. Circulation 112:I166–I172
Fandrich F, Lin X, Chai GX, Schulze M, Ganten D, Bader M, Holle J, Huang DS, Parwaresch R, Zavazava N, Binas B (2002) Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning. Nat Med 8:171–178
Schulze M, Ungefroren H, Bader M, Fandrich F (2006) Derivation, maintenance, and characterization of rat embryonic stem cells in vitro. Methods Mol Biol 329:45–58
Ladhoff J, Bader M, Brosel S, Effenberger E, Westermann D, Volk HD, Seifert M (2009) Low immunogenicity of endothelial derivatives from rat embryonic stem cell-like cells. Cell Res 19:507–518
Chinen J, Buckley RH (2010) Transplantation immunology: solid organ and bone marrow. J Allergy Clin Immunol 125:S324–S335
Otomo N, Margenthaler JA, Motoyama K, Arima T, Shimizu Y, Lehmann M, Flye MW (2001) Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration. J Surg Res 98: 59–65
Ladhoff J, Fleischer B, Hara Y, Volk HD, Seifert M (2010) Immune privilege of endothelial cells differentiated from endothelial progenitor cells. Cardiovasc Res 88:121–129
Acknowledgments
The authors would like to thank Prof. Michael Bader for supplying the rat RESC cell lines. Thanks also to Elke Effenberger and Sabine Brösel for skillful technical assistance and Meaghan Stolk for manuscript correction. We also thank the BMBF for supporting the work within the Berlin-Brandenburg Center for Regenerative Therapies (BCRT).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this protocol
Cite this protocol
Seifert, M., Ladhoff, J. (2013). Evaluation of Immunogenicity of Rat ES-Cell Derived Endothelial Cells. In: Zavazava, N. (eds) Embryonic Stem Cell Immunobiology. Methods in Molecular Biology, vol 1029. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-478-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-62703-478-4_4
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-477-7
Online ISBN: 978-1-62703-478-4
eBook Packages: Springer Protocols